(-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency

Brain Research

Volumn 1250, Issue , 2009, Pages 164-174

  Lee, Young Kyoung ^a   Yuk, Dong Yeon ^a   Lee, Jae Woong ^a   Lee, Sun Young ^a   Ha, Tae Youl ^b   Oh, Ki Wan ^a   Yun, Yeo Pyo ^a   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

( ) Epigallocatechin 3 gallate (EGCG); Alzheimer's disease (AD); Lipopolysaccharide (LPS); Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE; CYCLOOXYGENASE 2; DRINKING WATER; EPIGALLOCATECHIN GALLATE; GAMMA SECRETASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; BRAIN NERVE CELL; CELL DEATH; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENCEPHALITIS; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; APOPTOSIS; AVOIDANCE LEARNING; BRAIN; CATECHIN; CEREBRAL CORTEX; CYCLOOXYGENASE 2; HIPPOCAMPUS; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; NERVE TISSUE PROTEINS; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE FRAGMENTS;

EID: 58149302688     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.10.012     Document Type: Article

References (56)

1. Ahn S.C., Kim G.Y., Kim J.H., Baik S.W., Han M.K., and Lee H.J. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem. Biophys. Res. Commun. 313 (2004) 148-155
2. Aktas O., Prozorovski T., Smorodchenko A., Savaskan N.E., Lauster R., Kloetzel P.M., Infante-Duarte C., Brocke S., and Zipp F. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 17 (2004) 5794-5800
3. Antonio A.M., and Druse M.J. Antioxidants prevent ethanol-associated apoptosis in fetal rhombencephalic neurons. Brain Res. 1204 (2008) 16-23
4. Bastianetto S., Yao Z.X., Papadopoulos V., and Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur. J. Neurosci. 23 (2006) 55-64
5. Blasko I., Marx F., Steiner E., Hartmann T., and Grubeck-Loebenstein B. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 13 (1999) 63-68
6. Blasko I., Apochal A., Boeck G., Hartmann T., Grubeck-Loebenstein B., and Ransmayr G. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol. Dis. 8 (2001) 1094-1101
7. Brugg B., Dubreul Y.L., Huber G., Wollman E.E., Delhaye-Bouchaud N., and Mariani J. Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3032-3035
8. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., and Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10075-10078
9. Chauhan N.B., Siegel G.J., and Lichtor T. Distribution of intraventricularly administered antiamyloid-beta peptide antibody in the mouse brain. J. Neurosci. Res. 66 (2001) 231-235
10. Cho H.J., Kim S.K., Jin S.M., Hwang E.M., Kim Y.S., Huh K., and Mook-Jung I. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia 55 (2007) 253-262
11. Cho H.S., Kim S., Lee S.Y., Park J.A., Kim S.J., and Chun H.S. Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology 29 (2008) 656-662
12. Choi Y.T., Jung C.H., Lee S.R., Bae J.H., Baek W.K., Suh M.H., Park J., Park C.W., and Suh S.I. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 70 (2001) 603-614
13. Eikelenboom P., Zhan S.S., Van Gool W.A., and Allsop D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15 (1994) 447-450
14. Guo J.T., Yu J., Grass D., de Beer F.C., and Kindy M.S. Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J. Neurosci. 22 (2002) 5900-5909
15. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
16. Hauss-Wegrzyniak B., and Wenk G.L. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle. Neurosci. Lett. 32 (2002) 75-78
17. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., and Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 78 (1998) 294-303
18. Heneka M.T., and O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184 (2007) 69-91
19. Hirose Y., Imai Y., Nakajima K., Takemoto N., Toya S., and Kohsaka S. Glial conditioned medium alters the expression of amyloid precursor protein in SH-SY5Y neuroblastoma cells. Biochem. Biophys. Res. Commun. 19 (1994) 504-509
20. Hong J.T., Ryu S.R., Kim H.J., Lee J.K., Lee S.H., Kim D.B., Yun Y.P., Ryu J.H., Lee B.M., and Kim P.Y. Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain Res. Bull. 53 (2000) 743-749
21. Hong J.T., Ryu S.R., Kim H.J., Lee J.K., Lee S.H., Yun Y.P., Lee B.M., and Kim P.Y. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res. 88 (2001) 11-18
22. Jans D.M., Martinet W., Van De Parre T.J., Herman A.G., Bult H., Kockx M.M., and De Meyer G.R. Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease. Cardiovasc. Hematol. Disord. Drug Targets 6 (2006) 21-34
23. Kim H.S., Kim M.H., Jeong M., Hwang Y.S., Lim S.H., Shin B.A., Ahn B.W., and Jung Y.D. EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res. 24 (2004) 747-753
24. Laursen S.E., and Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods 16 (1986) 355-357
25. Lee J.W., Lee Y.K., Yuk D.Y., Choi D.Y., Ban S.B., Oh K.W., and Hong J.T. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflammation 5 (2008) 37
26. Lee S.Y., Nga N.T.H., Lee H., Yoo H.S., Yun Y.P., Oh K.W., Ha T.Y., and Hong J.T. Inhibitory effect of green tea extract on β-amyloid-induced PC12 cell death by inhibition of the activation of NF-κB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Mol. Brain Res. 14 (2005) 45-54
27. Levites Y., Amit T., Mandel S., and Youdim M.B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J. 17 (2003) 952-954
28. Li R., Huang Y.G., Fang D., and Le W.D. (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J. Neurosci. Res. 78 (2004) 723-731
29. Liao Y.F., Wang B.J., Cheng H.T., Kuo L.H., and Wolfe M.S. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J. Biol. Chem. 27 (2004) 49523-49532
30. Lim G.P., Yang F., Chu T., Chen P., Beech W., Teter B., Tran T., Ubeda O., Ashe K.H., Frautschy S.A., and Cole G.M. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20 (2000) 5709-57014
31. Maeda J., Ji B., Irie T., Tomiyama T., Maruyama M., Okauchi T., Staufenbiel M., Iwata N., Ono M., Saido T.C., Suzuki K., Mori H., Higuchi M., and Suhara T. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J. Neurosci. 27 (2007) 10957-10968
32. Mandel S., einreb O., Amit T., and Youdim M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem. 88 (2004) 1555-15569
33. Mandel S., Amit T., Bar-Am O., and Youdim M.B. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents. Prog. Neurobiol. 82 (2007) 348-360
34. McGeer P.L., and Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42 (1992) 447-449
35. Miklossy J., Kis A., Radenovic A., Miller L., Forro L., Martins R., Reiss K., Darbinian N., Darekar P., Mihaly L., and Khalili K. Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol. Aging 27 (2006) 228-236
36. Milatovic D., Zaja-Milatovic S., Montine K.S., Horner P.J., and Montine T.J. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J. Neurochem. 87 (2003) 1518-1526
37. Morris R. Developments of water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
38. Muramatsu K., Fukuyo M., and Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 32 (1986) 613-622
39. Nichol K.E., Poon W.W., Parachikova A.I., Cribbs D.H., Glabe C.G., and Cotman C.W. Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J. Neuroinflammation 5 (2008) 13 Apr 9
40. Okello E.J., Savelev S.U., and Perry E.K. In vitro anti-beta-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia. Phytother. Res. 18 (2004) 624-647
41. Patel J.R., and Brewer G.J. Age-related changes in neuronal glucose uptake in response to glutamate and beta-amyloid. J. Neurosci. Res. 72 (2003) 527-536
42. Pratico D., and Trojanowski J.Q. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?. Neurobiol. Aging 21 (2000) 441-445
43. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., Ehrhart J., Townsend K., Zeng J., Morgan D., Hardy J., Town T., and Tan J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 25 (2005) 8807-8814
44. Reznichenko L., Amit T., Zheng H., Avramovich-Tirosh Y., Youdim M.B., Weinreb O., and Mandel S. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. J. Neurochem. 97 (2006) 527-536
45. Rietveld A., and Wiseman S. Antioxidant effects of tea: evidence from human clinical trials. J. Nutr. 133 (2003) 3285S-3292S
46. Sastre M., Dewatcher I., Landreth G.E., Willson T.M., Klockgether T., van Leuven F., and Heneka M.T. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J. Neurosci. 23 (2003) 9796-9804
47. Sparkman N.L., Martin L.A., Calvert W.S., and Boehm G.W. Effects of intraperitoneal lipopolysaccharide on Morris maze performance in year-old and 2-month-old female C57BL/6J mice. Behav. Brain Res. 15 (2005) 145-151
48. Storey E., and Cappai R. The amyloid precursor protein of Alzheimer's disease and the Abeta peptide. Neuropathol. Appl. Neurobiol. 25 (1999) 81-97
49. Sung S., Yang H., Uryu K., Lee E.B., Zhao L., Shineman D., Trojanowski J.Q., Lee V.M., and Praticò D. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am. J. Pathol. 165 (2004) 2197-2206
50. Walsh D.M., and Selkoe D.J. Abeta oligomers - a decade of discovery. J. Neurochem. 101 (2007) 1172-1184
51. Xu F., Grande A.M., Robinson J.K., Previti M.L., Vasek M., Davis J., and Van Nostrand W.E. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience 146 (2007) 98-107
52. Yamamoto M., Kiyota T., Horiba M., Buescher J.L., Walsh S.M., Gendelman H.E., and Ikezu T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 170 (2007) 680-692
53. Yan Q., Zhang J., Liu H., Babu-Khan S., Vassar R., Biere A.L., Citron M., and Landreth G. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci. 23 (2003) 7504-7509
54. Yogev-Falach M., Amit T., Bar-Am O., Weinstock M., and Youdim M.B. Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline. FASEB J. 16 (2002) 1674-1676
55. Zhang B., Rusciano D., and Osborne N.N. Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Res. 1198 (2008) 141-152
56. Zhao Q., and Lee F.S. The transcriptional activity of the APP intracellular domain-Fe65 complex is inhibited by activation of the NF-kappaB pathway. Biochemistry 42 (2003) 3627-3634